Literature DB >> 15970010

Recombinant LH in ovarian stimulation.

Gamze Sinem Caglar1, Byron Asimakopoulos, Nikos Nikolettos, Klaus Diedrich, Safaa Al-Hasani.   

Abstract

The advent of recombinant gonadotrophins brought significant changes in fertility therapy. Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis. Over a decade, recombinant LH (rLH) has been used for clinical trials, and the amount of peripheral LH that is necessary for optimal follicular growth, oocyte maturation, subsequent embryo development and assisted reproduction outcome during ovulation induction can now be better evaluated. This review evaluates the effect of rLH supplementation on ovarian stimulation and assisted reproduction outcome. The studies conducted with rLH supplementation in ovarian stimulation in different groups of patients and in cases of controlled ovarian stimulation are clearly discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15970010     DOI： 10.1016/s1472-6483(10)61123-6

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN： 1472-6483            Impact factor:   3.828


  6 in total

1.  Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.

Authors:  Zhaolian Wei; Xianxia Cheng; Huirong Li; Yunxia Cao; Lin Cong; Ping Zhou; Jun Li
Journal:  Reprod Biol Endocrinol       Date:  2010-03-17       Impact factor: 5.211

2.  Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Shabnam Khodabakhshi; Mohammad Reza Akhoond; Fatemeh Hasani
Journal:  J Assist Reprod Genet       Date:  2012-09-07       Impact factor: 3.412

3.  Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.

Authors:  Marzia Barberi; Beatrice Ermini; Maria Beatrice Morelli; Michele Ermini; Sandra Cecconi; Rita Canipari
Journal:  J Assist Reprod Genet       Date:  2012-11-28       Impact factor: 3.412

4.  Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trial.

Authors:  Mohammad-Hossein Razi; Fereshteh Mohseni; Razieh Dehghani Firouzabadi; Sima Janati; Nahid Yari; Sahabeh Etebary
Journal:  Iran J Reprod Med       Date:  2014-02

5.  A cohort study of both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition at early follicular stage in in vitro fertilization outcome: A STROBE-compliant study.

Authors:  Xi Xia; Yu Shi; Lan Geng; Dan Liu; Zhenhui Hou; Hongbo Lin; Rong Li; Haiyan Wang; Liyuan Tao; Fanhua Meng; Jian Da; Yun Chen; Jie Qiao; Weiping Qian; Hongzhen Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study.

Authors:  José G Franco; Ricardo L R Baruffi; João Batista A Oliveira; Ana L Mauri; Claudia G Petersen; Paula Contart; Valeria Felipe
Journal:  Reprod Biol Endocrinol       Date:  2009-06-04       Impact factor: 5.211
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.